Xiaoling Wu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
Papers in
-
- RNA modifications and cancer 13
- Circular RNAs in diseases 8
- Epigenetics and DNA Methylation 7
- RNA Research and Splicing 6
- Cancer-related gene regulation 5
- DNA Repair Mechanisms 3
-
- Cancer-related molecular mechanisms research 15
- MicroRNA in disease regulation 11
- Co-authors
- Dongge Cai (3 shared papers)Yidong Wang (4 shared papers)Bo Liu (2 shared papers)Jinjun Guo (2 shared papers)Xia Zhang (2 shared papers)Bo Ning (2 shared papers)Hongbin Zhang (1 shared paper)Zhenzhen Zhang (1 shared paper)
- Journals
- Oncology Reports (4 papers)PLoS ONE (3 papers)Cancer Management and Research (2 papers)American Journal of Cancer Research (2 papers)Cell Death Discovery (1 paper)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Xiaoling Wu
52 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 83
- Cancer Research 475
- Molecular Biology 658
- Oncology 132
- Immunology 65
- Neurology 34
Countries citing papers authored by Xiaoling Wu
This map shows the geographic impact of Xiaoling Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Wu more than expected).
Fields of papers citing papers by Xiaoling Wu
This network shows the impact of papers produced by Xiaoling Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Wu. The network helps show where Xiaoling Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 163 | |
| 2 | 2014 | 72 | |
| 3 | 2014 | 46 | |
| 4 | 2017 | 46 | |
| 5 | 2015 | 44 | |
| 6 | 2021 | 33 | |
| 7 | 2023 | 30 | |
| 8 | 2020 | 30 | |
| 9 | 2018 | 30 | |
| 10 | 1999 | 30 | |
| 11 | Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer. | 2001 | 29 |
| 12 | 2020 | 28 | |
| 13 | 2017 | 27 | |
| 14 | 2019 | 26 | |
| 15 | 2019 | 25 | |
| 16 | 2020 | 25 | |
| 17 | 2020 | 24 | |
| 18 | 2023 | 24 | |
| 19 | 2017 | 23 | |
| 20 | 2014 | 23 |
About Xiaoling Wu
Xiaoling Wu is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Cell Biology, having authored 54 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (15 papers), RNA modifications and cancer (13 papers), MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (8 papers), Epigenetics and DNA Methylation (7 papers), RNA Research and Splicing (6 papers), Cancer-related gene regulation (5 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Cancer Research (475 citations), Molecular Biology (658 citations), Oncology (132 citations), Immunology (65 citations) and Neurology (34 citations). Xiaoling Wu has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Dongge Cai, Yidong Wang, Bo Liu, Jinjun Guo, Xia Zhang, Bo Ning, Hongbin Zhang, Zhenzhen Zhang, Peng Yang and Yanmin Liu. Their work appears in journals such as Oncology Reports, PLoS ONE, Cancer Management and Research, American Journal of Cancer Research and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.